Q4 FY2025 · ended Dec 31, 2025 · Revenue $-90,000, -742.9% YoY · Filed Mar 24, 2026
Fractyl Health, Inc. (GUTS) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. As of Jun 30, 2026 it held $47.1 million in cash and investments and $30.3 million in total debt.
Revenue
$-90,000
-742.9% vs prior quarter
Net income
$-25.54M
+8.4% vs year-ago quarter
Operating cash flow
$-15.90M
+25.0% vs year-ago quarter
Free cash flow
$-21.34M
-23.6% vs year-ago quarter
EPS
$-0.16
+71.9% vs year-ago quarter
Dividend per share
None
Shares outstanding
159.18M
+216.5% vs year-ago quarter
Net cash
$16.85M
Q2 FY2026
Operating margin
25871.1%
Q4 FY2025
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- GUTS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Burlington, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1572616
- Former names
- Fractyl Laboratories Inc. (until Mar 19, 2020)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | — | — | -$90,000 | — | — |
| Operating income | -$19.1M | -$20.8M | -$23.3M | -$22.7M | -$26.1M |
| Net income | -$25.5M | $9.2M | -$43.7M | -$45.6M | -$27.9M |
| Diluted EPS | -$0.16 | $0.06 | -$0.31 | -$0.71 | -$0.57 |
| Operating cash flow | -$15.9M | -$22.5M | -$21.3M | -$22.7M | -$21.2M |
| Free cash flow | — | — | -$21.3M | -$23.3M | -$21.3M |
| Total assets | $82.0M | $99.4M | $121.4M | $114.3M | $62.0M |
| Total liabilities | $83.6M | $78.0M | $111.9M | $117.5M | $80.2M |
| Stockholders' equity | -$1.7M | $21.4M | $9.5M | -$3.2M | -$18.2M |
| Cash and investments | $47.1M | $63.2M | $81.5M | $77.7M | $22.3M |
| Total debt | $30.3M | $30.7M | $31.1M | $31.4M | $31.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Other events
|
Oct 22, 2026 | Oct 21, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 16, 2026 | Oct 16, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 1, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 24, 2026 | Sep 24, 2026 |
| 8-K |
Current report
Listing notice
|
Sep 11, 2026 | Sep 10, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
All 227 Fractyl Health, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.